CARLYN FULTON: Open Payments
NPI 1134843246 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$531 in 22 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $221 · 2025 $531
Food & beverage: $531
| Company | Payments | Amount |
|---|---|---|
| Exeltis, USA Inc. | 4 | $162 |
| Sage Therapeutics, LLC | 3 | $71 |
| Astellas Pharma US Inc | 2 | $54 |
| Evofem Biosciences, Inc. | 2 | $45 |
| Hologic Sales and Service, LLC | 2 | $42 |
| Supernus Pharmaceuticals, Inc. | 2 | $42 |
| MAYNE PHARMA COMMERCIAL LLC | 3 | $37 |
| Exact Sciences Corporation | 2 | $33 |
| Organon LLC | 1 | $23 |
| SHIELD THERAPEUTICS INC | 1 | $21 |
Products named: TWIRLA, ZURZUVAE, Veozah, Phexxi, SLYND, APTIMA, Qelbree, Cologuard Collection Kit.
Industry payments across MD — which companies pay providers there.
